'Advocacy groups are the connectors': Experiences and contributions of rare disease patient organization leaders in advanced neurotherapeutics
Abstract Introduction Biomedical progress has facilitated breakthrough advanced neurotherapeutic interventions, whose potential to improve outcomes in rare neurological diseases has increased hope among people with lived experiences and their carers. Nevertheless, gene, somatic cell and other advanc...
Saved in:
Main Authors: | Christina Q. Nguyen (Author), Didu Kariyawasam (Author), Kristine Alba‐Concepcion (Author), Sarah Grattan (Author), Kate Hetherington (Author), Claire E. Wakefield (Author), Susan Woolfenden (Author), Russell C. Dale (Author), Elizabeth E. Palmer (Author), Michelle A. Farrar (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2022-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Editorial: Cannabidiol Treatment in Neurotherapeutic Interventions
by: Gustavo Gonzalez-Cuevas, et al.
Published: (2021) -
Editorial: Cannabidiol treatment in neurotherapeutic interventions, volume II
by: Gustavo Gonzalez-Cuevas, et al.
Published: (2023) -
Mechanisms of manganese-induced neurotoxicity and the pursuit of neurotherapeutic strategies
by: Edward Pajarillo, et al.
Published: (2022) -
Cubosomes: evolving platform for intranasal drug delivery of neurotherapeutics
by: Priyanka Gawarkar-Patil, et al.
Published: (2024) -
Aesthetic rehabilitation with multiple loop connectors
by: Ashish Kalra, et al.
Published: (2013)